Cargando…

Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease

Background: H1-antihistamines (H1AH) represent the current mainstay of treatment for chronic spontaneous urticaria (CSU). However, the response to H1AH is often unsatisfactory, even with increased doses. Therefore, guidelines recommend the use of omalizumab as an add-on treatment in refractory CSU....

Descripción completa

Detalles Bibliográficos
Autores principales:	Manti, Sara, Giallongo, Alessandro, Papale, Maria, Parisi, Giuseppe Fabio, Leonardi, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369449/ https://www.ncbi.nlm.nih.gov/pubmed/35956071 http://dx.doi.org/10.3390/jcm11154453

Ejemplares similares

Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon
por: Manti, Sara, et al.
Publicado: (2021)

Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review
por: Manti, Sara, et al.
Publicado: (2022)

Biologic drugs in chronic spontaneous urticaria
por: Licari, Amelia, et al.
Publicado: (2021)

Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population
por: Pulvirenti, Giulio, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre
por: Manti, Sara, et al.
Publicado: (2022)

Lower Airway Microbiota
por: Pulvirenti, Giulio, et al.
Publicado: (2019)

Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease
por: Giallongo, Alessandro, et al.
Publicado: (2023)

Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2022)

Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer
por: Presti, Santiago, et al.
Publicado: (2022)

Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic
por: Presti, Santiago, et al.
Publicado: (2023)

Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
por: Manti, Sara, et al.
Publicado: (2021)

Type 2 inflammation in cystic fibrosis: New insights
por: Manti, Sara, et al.
Publicado: (2022)

Cystic Fibrosis: Fighting Together Against Coronavirus Infection
por: Manti, Sara, et al.
Publicado: (2020)

Focus on gastroesophageal reflux disease in patients with cystic fibrosis
por: Bongiovanni, Annarita, et al.
Publicado: (2020)

Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis
por: Manti, Sara, et al.
Publicado: (2021)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2023)

Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia
por: Papale, Maria, et al.
Publicado: (2023)

Lactoferrin: Cytokine Modulation and Application in Clinical Practice
por: Presti, Santiago, et al.
Publicado: (2021)

Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: a randomized controlled study
por: Manti, Sara, et al.
Publicado: (2020)

Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2021)

Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy
por: Manti, Sara, et al.
Publicado: (2020)

Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: a pilot study
por: Papale, Maria, et al.
Publicado: (2021)

Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination
por: Manti, Sara, et al.
Publicado: (2020)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study
por: Giugno, Andrea, et al.
Publicado: (2022)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life
por: Galletta, Francesca, et al.
Publicado: (2023)

Treatment of Chronic Spontaneous Urticaria
por: Kaplan, Allen P.
Publicado: (2012)

Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Chronic urticaria and drug hypersensitivity in children
por: Carla, Mastrorilli, et al.
Publicado: (2019)

Immunological events in chronic spontaneous urticaria
por: Ferrer, Marta
Publicado: (2015)

Autoimmune Theories of Chronic Spontaneous Urticaria
por: Bracken, Sonali J., et al.
Publicado: (2019)

Emerging Therapies in Chronic Spontaneous Urticaria
por: Min, Taek Ki, et al.
Publicado: (2019)

Chronic Spontaneous Urticaria: An Etiopathogenic Study
por: Maheshwari, Apoorva, et al.
Publicado: (2022)

Definition of Recurrent Chronic Spontaneous Urticaria
por: MELÉ-NINOT, Gemma, et al.
Publicado: (2020)

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Novel therapeutic targets for allergic airway disease in children
por: Giallongo, Alessandro, et al.
Publicado: (2019)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jr14tb1stoqhsme0e015b6vfqp